Multiple Sclerosis Clinical Trials in Scottsdale, Arizona

3 studies are recruiting for multiple sclerosis in Scottsdale, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

    The purpose of this study is to assess the imaging biomarkers, patient outcomes, safety, tolerability, and treatment satisfaction of ocrelizumab (OCR) combined with recombinant human hyaluronidase (rHuPH20) administered subcutaneously (SC) in participants with relapsing multiple sclerosis (RMS) or …

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    Clinical Endpoints, LLC, Scottsdale, Arizona
    Locations
    5 in total
    Run by
    Genentech, Inc.

    See if you can join NCT07609719 on ClinicalTrials.gov

  2. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

    Stage
    Not phased
    Ages
    18 and older
    Site
    TG Therapeutics Investigational Trial Site, Scottsdale, Arizona
    Locations
    111 in total
    Run by
    TG Therapeutics, Inc.

    See if you can join NCT06433752 on ClinicalTrials.gov

  3. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

    This is a randomized, open-label, parallel, Phase 3 study with 2-arms for treatment. The purpose of this study is to evaluate SC administration of frexalimab every 4 weeks (q4w) compared to IV administration of frexalimab q4w in male and female participants with RMS and nrSPMS (aged 18 to 60 years …

    Stage
    Phase 3
    Ages
    18 to 60
    Site
    Perseverance Research Center- Site Number : 8400138, Scottsdale, Arizona
    Locations
    40 in total
    Run by
    Sanofi

    See if you can join NCT07325292 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.